ꓴꓢꓮ ꓗꓪ ꓔꓬ ꓟ 65 ꓘꓳꓼ ꓕꓯꓽ ꓢꓲ ꓡꓳꓼ ꓢꓴ ꓐꓴ ꓔꓯ ꓚꓳꓦꓲꓓ-19 ꓠꓻ ꓗꓽ ꓠꓯ ꓞꓲꓼ Pfizer ꓗꓯꓸ ꓔꓺ ꓓꓴ ꓕꓵꓼ ꓪ ꓔꓯ ꓝꓓꓮ ꓡꓰ ꓢꓷ ꓙ ꓟꓴ ꓙ ꓩꓴ ꓡ ꓡꓳ꓿
ꓗꓴꓷꓼ ꓠꓯꓼ ꓗꓪ ꓟ ꓞꓲꓼ ꓟꓳꓽ ꓢꓴ ꓐꓴ ꓔꓯ ꓢꓯꓼ ꓟꓬꓠꓚꓬꓴꓹ ꓟꓬꓱꓽ ꓥ ꓠꓬꓲ꓾ ꓡꓳ ꓒꓱ ꓙꓵꓽ ꓢꓴ ꓐꓴ ꓠꓲꓹ ꓞ ꓟꓬꓱꓽ ꓬꓰ ꓠꓹ ꓟ ꓴꓢꓮ ꓝꓓꓮ ꓐꓯ ꓩꓴ ꓡ ꓡꓳ꓿
ꓴꓢꓮ ꓗꓪ ꓕꓲ ꓟꓲ ꓠꓯ ꓗꓪ ꓐꓰ ꓮ ꓘꓶꓸ ꓙꓲ ꓡꓳ ꓐꓰ ꓢꓪꓼ ꓔꓸ ꓟ ꓚꓳꓦꓲꓓ-19 ꓠꓻ ꓗꓽ ꓠꓯ ꓞꓲꓼ ꓕꓱ ꓡꓱ ꓗꓯꓸ ꓖꓶ ꓔꓬ ꓥ ꓟꓲ꓾ ꓗꓯꓸ ꓠꓲꓹ ꓟꓽ ꓫꓵ ꓢꓴ ꓔꓬ ꓢꓰ ꓡꓳ꓿
JUST IN: The FDA says it will grant emergency use authorization for a booster dose of Pfizer’s Covid-19 vaccine in people 65 and older, people at high risk of severe disease and people whose jobs put them at risk of infection. The CDC must give its stamp of approval for any booster doses to be officially given.